US FDA Approves Export of 3 Million Janssen Vaccine Doses to Brazil

[Image source=Yonhap News]

[Asia Economy Reporter Cho Hyun-ui] The U.S. Food and Drug Administration (FDA) has authorized the export of 3 million doses of the Janssen COVID-19 vaccine to Brazil.

Brazil's Ministry of Health announced on the 12th (local time) that the FDA has approved the export of the Janssen vaccine, and although the exact date has not been set, it is expected to arrive next week.

The expiration date of the Janssen vaccines imported by Brazil is until the 27th of this month, so vaccinations are expected to be carried out promptly upon arrival.

The import of Janssen vaccines by Brazil is happening earlier than planned.

Previously, Brazil had signed a contract to import 38 million doses of the Janssen vaccine, with 16.9 million doses scheduled to arrive between July and September, and 21.1 million doses between October and December.

In Brazil, vaccinations with the Chinese Sinovac and British AstraZeneca (AZ) vaccines began in mid-January, followed by the addition of the U.S. Pfizer vaccine. With the arrival of the Janssen vaccine, the total will increase to four types.

This content was produced with the assistance of AI translation services.